References
- Johanson B. Isolation of an iron-containing red protein from human milk. Acta Chem Scand 1960; 14: 510–2
- Arnold R R, Brewer M, Gauthier J J. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun 1980; 28: 893–8
- Breton-Gorius J, Mason D Y, Buriot D, Vilde J L, Griscelli C. Lactoferrin deficiency as a consequence of lack of specific granules in neutrophils from a patient with recurrent infections. Am J Pathol 1980; 99: 413–9
- Arnold R R, Cole M F, McGhee J R. A bactericidal effect for human lactoferrin. Science 1977; 197: 263–5
- Weinberg E D. Iron with holding: a defence against infection and neoplasia. Physiol Rev 1984; 64: 65–102
- Lönnerdal B, Iyer S. Lactoferrin: molecular structure and biological function. Annu Rev Nutr 1995; 15: 93–110
- Danjo Y, Lee M, Horimoto K, Hamamoto T. Ocular surface damage and tear lactoferrin in dry eye syndrome. Acta Ophthalmol 1994; 72: 433–7
- Blaser M J. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992; 102: 720–7
- Dixon M F. Helicobacter pylori and peptic ulceration: histo-pathological aspects. J Gastroenterol Hepatol 1991; 6: 125–30
- Parsonnet J, Freedman G D, Vandersteen D P, Chang V Y, Vogelman J H, Orentreich N, et al. Helicobacter pylori infection and risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–31
- Hussell T, Isaacson P G, Crabtree J E, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571–4
- Crabtree J E, Wyatt J I, Trejdosiewcz L K, Peichl P, Nichols P H, Ramsay N, et al. Interleukin-8 expression in Helicobacter pylori infected, normal and neoplastic gastroduodenal mucosa. J Clin Pathol 1994; 47: 61–6
- Rauws E AJ, Langenberg W, Houthoff H J, Zanen H C. Campylobacter pyloridis-associated chronic active antral gastritis; a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94: 33–40
- Gossens H, Glupczynski Y, Burette A, Van den Borre C, Deprez C, Bodenmann J, et al. Evaluation of a commercially available complement fixation test for diagnosis of Helicobacter pylori infection and for follow-up after antimicrobial therapy. J Clin Microbiol 1992; 30: 3230–3
- Price A B. The Sydney system: histological division. J Gastroenterol Hepatol 1991; 6: 209–22
- Tsuchihashi K, Imoto J, Shibata T, Takaji S, Ikemura N, Taguchi Y, et al. Usefulness of measuring intragastric ammonia levels as a screening method for diagnosis of Helicobacter pylori infection. Gastrenterol Endosc 1993; 35: 253–60
- Bezwoda W R, Baynes R D, Khan Q, Mansoor N. Enzyme linked immunosorbent assay for lactoferrin plasma and tissue measurements. Clin Chim Acta 1985; 151: 61–9
- Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54
- Luqmani Y A, Campbell T A, Bennett C, Coombes R C, Paterson I M. Express of lactoferrin in human stomach. Int J Cancer 1991; 49: 684–7
- Suzuki T, Nonaka M, Kiyosawa I, Ogasa K. Peptic digestion of human and bovine lactoferrin. J Jpn Soc Nutr Food Sci 1978; 31: 395–403
- Brock J H, Arzabe F, Lampreave F, Pineiro A. The effect of trypsin on bovine transferrin and lactoferrin. Biochim Biophys Acta 1976; 446: 214–25
- Warren J R, Marshall B J. Unidentified curved bacilli on gastric epithelium in chronic gastritis. Lancet 1983; 1: 1273–5
- Hazall S L, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucous as an important factors in colonization of the gastric epithelium. J Infect Dis 1986; 153: 658–63
- Tsujii M, Kawano S, Tsuji S, Fusamoto H, Kamada T, Sato N. Mechanism of gastric mucosal damage induced by ammonia. Gastroenterology 1992; 102: 1881–8
- Cover T L, Cao P, Lind C D, Tham K T, Blaser M J. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993; 61: 5008–12
- Davics G R, Simmonds N J, Stevens T RJ, Sheaff M T, Banatvala N, Laurenson I F, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179–85
- Marshall B J. Virulence and pathogenicity of Helicobacter pylori. 1. Gastroenterol Hepatol 1992; 6: 121–4
- Husson M O, Legrand D, Spik G, Leclerc H. Iron acquisition by Helicobacter pylori: importance of human lactoferrin. Infect Immun 1993; 61: 2694–7
- Dial E J, Serna J A, Lichtenberger L M. Lactoferrin inhibits the growth of Helicobacter pylori in vitro. Gastroenterology 1995; 108: A82
- Dial E J, Hall L R, Lichtenberger L M. Antimicrobial properties of lactoferrin which limit Helicobacter pylori (HP) growth. Gastroenterology 1996; 110: A95
- Miehlke S, Osato M S, Reddy R, Ward P P, Conneely O M, Graham D Y. Direct antibacterial activity of recombinant human lactoferrin against. Helicobacter pylori Gastroenterology 1996; 110: A196
- Ellison R T, Giehl T J, Laforce F M. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun 1988; 61: 719–28
- Yamauchi K, Tomita M, Giehl T J, Ellison R T, III. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 1993; 61: 719–28
- Ward P P, Piddington C S, Cunningham G A, Zhou X, Wyatt R D, Conneely O M. A system for production of commercial quantities of human lactoferrin, a broad spectrum natural antibiotic. Biotechnology 1995; 13: 498–503